Clinical Study to Evaluate the Effectiveness, Safety, and Tolerability of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects

NCT02687451 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

28

Enrollment

INDUSTRY

Sponsor class

Stopped Released from PMR

Conditions

Post-Operative Pain
Acute Pain

Interventions

DRUG: Oxymorphone HCl
DRUG: Placebo

Sponsor

Endo Pharmaceuticals